MANA.BIO

manabio-logo

Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines.

#People #Website #More

MANA.BIO

Social Links:

Industry:
Biotechnology

Website Url:
http://www.mana.bio

Status:
Active



Current Advisors List

peter-nell_image

Peter Nell Advisory Board Member @ Mana.bio
Board_member
2022-05-01

Official Site Inspections

http://www.mana.bio

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.171
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Mana.bio"

Mana.bio - Crunchbase Company Profile & Funding

Mana.bio evaluates lipid nanoparticles for efficacy, safety, and physicochemical properties through high-throughput screening. Machine Learning Model โ€ฆSee details»

Mana.bio 2025 Company Profile: Valuation, Funding

What is the size of Mana.bio? Mana.bio has 25 total employees. What industry is Mana.bio in? Mana.bioโ€™s primary industry is Drug Delivery. Is Mana.bio a โ€ฆSee details»

Technology - Mana.bio

Mana.bio thoroughly evaluates each constructed lipid nanoparticle through automated, high-throughput screening infrastructure including assays that analyze efficacy, safety and physicochemical properties to identify top โ€ฆSee details»

Mana.bio Company Profile - Office Locations, Competitors ... - Craft

Mana.bio Summary. Company Summary. Overview. Mana.bio is a company providing AI based drug delivery solutions. It develops a platform for lipid nanoparticle (LNP) development for โ€ฆSee details»

Mana.bio | BIO-Europe Spring - Informa Connect

Mana Bio is a biotech start-up leveraging data, machine learning, and high throughput screening to design novel LNPs for extrahepatic delivery of nucleic acid therapeutics and vaccines. Mana โ€ฆSee details»

Mana.bio - Funding, Financials, Valuation & Investors - Crunchbase

Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines. New. Resources. Advanced Search. ... How much funding โ€ฆSee details»

Mana.bio - Israeli Startup | Startup Nation Finder

Oct 10, 2023 Mana.bio has created a platform for lipid nanoparticle development for oligonucleotide therapies, including mRNA-based therapeutics, vaccines, and gene therapy. โ€ฆSee details»

Mana.bio: Israeli Startup Debuts AI-Driven Drug Therapy

Oct 13, 2023 Mana.bio is harnessing the power of AI to craft lipid nanoparticles (LNPs), aiming to revolutionize drug treatments. "Our unique blend of hands-on experimentation and machine โ€ฆSee details»

Mana.bio - VentureRadar

Mana.bio is building an AI-based drug delivery platform, focusing on the delivery of oligonucleotide therapies, including mRNA-based therapeutics, vaccines, and gene therapy. โ€ฆSee details»

Mana.bio Advances AI-Based Lipid Nanoparticle (LNP) โ€ฆ

Oct 10, 2023 Mana.bio's unique approach, which is based on academic research from the Technion Institute of Technology, cycles through design, build, test and learn steps that are enabled by artificial ...See details»

Mana.bio | Falling Walls

Mana.bio leverages Artificial Intelligence (AI)/ Machine Learning (ML) to design novel non-viral ex-liver cell-specific RNA delivery solutions. Mana Bio is a biotech start-up leveraging data, โ€ฆSee details»

Mana.bio | Companies | RadialReport - Aging Analytics Agency

Artificial intelligence-based drug delivery startup companyMana.bio operates as an artificial intelligence-based drug delivery startup company. It creates a platform for Lipid Nanoparticle โ€ฆSee details»

Mana.bio | StartupHub.ai

Jun 1, 2021 Mana.bio is an AI-based drug delivery startup that focuses on developing a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies, including mRNA โ€ฆSee details»

Mana.bio CEO and Key Executive Team | Craft.co

Mana.bio's Co-Founder & CEO is Yogev Debbi. Other executives include Roy Nevo, Co-Founder & CTO; Kira Radinsky, Scientific Co-Founder and 2 others. See the full leadership team at Craft.See details»

Mana.bio closes oversubscribed $19.5M seed funding

โ€“ Led by a multidisciplinary team with expertise in drug delivery, nanotechnology, and machine learning, Mana.bio closes oversubscribed $19.5M seed funding from Andreessen Horowitz Bio โ€ฆSee details»

Mana.bio - Contacts, Employees, Board Members, Advisors & Alumni

Organization. Mana.bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. ... Mana.bio has 2 board โ€ฆSee details»

Press Releases | CAS

Mana.bio integrates CAS chemical substance data into its novel drug delivery AI platform. June 22, 2022. ... The 2017 best life science contract research organization (CRO), ChemPartner, โ€ฆSee details»

Mana.bio integrates CAS chemical substance data into its novel โ€ฆ

An agreement to embed chemical substance data from the CAS Content CollectionTM directly into the Mana.bio AI data acquisition workflow via an application programmable interface โ€ฆSee details»

Mana (skeleton) - Wikipedia

Mana is the name given to a complete human skeleton discovered in Moturiki, Fiji, belonging to a Lapita woman that lived in approximately 800 BCE. Being the best preserved Lapita-age โ€ฆSee details»

Mana.bio - Updates, News, Events, Signals & Triggers - Crunchbase

Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines.See details»